Cytokinetics shares owned by Peregrine Capital Management
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Peregrine Capital Management
from 13F filings
Historical chart of Peregrine Capital Management investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Peregrine Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Peregrine Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $8.9M | 126k | 70.11 |
| 2023-12-31 | $11M | 132k | 83.49 |
| 2023-09-30 | $6.0M | 205k | 29.46 |
| 2023-06-30 | $5.9M | 181k | 32.62 |
| 2023-03-31 | $7.0M | 199k | 35.19 |
| 2022-12-31 | $7.3M | 160k | 45.82 |
| 2022-09-30 | $7.2M | 149k | 48.45 |
| 2022-06-30 | $6.9M | 175k | 39.29 |
| 2022-03-31 | $8.1M | 220k | 36.81 |
| 2021-12-31 | $9.9M | 216k | 45.58 |
| 2021-09-30 | $10M | 289k | 35.74 |
| 2021-06-30 | $8.4M | 424k | 19.79 |
| 2021-03-31 | $10M | 447k | 23.26 |
| 2020-12-31 | $12M | 556k | 20.78 |
More positions owned by Peregrine Capital Management
View all positions for Peregrine Capital Management